UroGen Pharma Ltd. (URGN)
NASDAQ: URGN
· Real-Time Price · USD
19.74
-0.34 (-1.69%)
At close: Aug 15, 2025, 3:59 PM
19.50
-1.22%
After-hours: Aug 15, 2025, 06:59 PM EDT
UroGen Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 24.21M | 20.25M | 24.57M | 25.2M | 21.85M | 18.78M | 23.53M | 20.85M | 21.14M | 17.19M | 18.09M | 16.1M | 16.6M | 13.56M | 16.17M | 11.35M | 13.03M | 7.49M |
Cost of Revenue | 3.55M | 2.33M | 2.47M | 2.45M | 2.23M | 1.73M | 2.29M | 2.37M | 2.44M | 2.27M | 2.26M | 2.02M | 1.85M | 1.52M | 1.59M | 1.24M | 1.43M | 897K |
Gross Profit | 20.66M | 17.92M | 22.09M | 22.75M | 19.62M | 17.05M | 21.24M | 18.48M | 18.7M | 14.93M | 15.83M | 14.08M | 14.76M | 12.04M | 14.59M | 10.11M | 11.61M | 6.59M |
Operating Income | -41.45M | -36.91M | -27.66M | -17.55M | -25.84M | -25.74M | -14.61M | -13.5M | -15.38M | -22.05M | -20.28M | -18.09M | -18.71M | -21.96M | -19.91M | -23.44M | -22.82M | -26.11M |
Interest Income | 1.68M | 2.2M | 2.81M | 2.76M | 1.72M | 1.8M | 726K | 835K | 405K | 645K | 406K | 441K | 128K | 2K | 20K | 57K | 33K | 167K |
Pretax Income | -48.92M | -43.45M | -34.86M | -23.58M | -33.37M | -32.23M | -22.16M | -21.89M | -24.08M | -30.19M | -28.18M | -25.12M | -26.66M | -28.07M | -27.32M | -30.21M | -25.91M | -25.93M |
Net Income | -49.94M | -43.84M | -37.51M | -23.67M | -33.4M | -32.29M | -26.02M | -21.88M | -24.14M | -30.21M | -28.25M | -25.83M | -26.69M | -28.39M | -28.45M | -30.21M | -26.22M | -25.93M |
Selling & General & Admin | 43.2M | 34.97M | 34.86M | 28.94M | 30.06M | 27.3M | 24.55M | 21.75M | 22.49M | 24.47M | 21.63M | 19.07M | 20.83M | 21.3M | 21.42M | 21.62M | 22.3M | 22.19M |
Research & Development | 18.91M | 19.87M | 14.89M | 11.36M | 15.4M | 15.49M | 11.3M | 10.23M | 11.58M | 12.5M | 14.48M | 13.09M | 12.64M | 12.7M | 13.08M | 11.92M | 12.12M | 10.51M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -30K | n/a | n/a | 37K | n/a | -4K | n/a | n/a | n/a | n/a |
Operating Expenses | 62.11M | 54.84M | 49.75M | 40.3M | 45.46M | 42.79M | 35.85M | 31.98M | 34.08M | 36.97M | 36.11M | 32.16M | 33.47M | 34M | 34.5M | 33.55M | 34.43M | 32.7M |
Interest Expense | 8.78M | 8.65M | 3.89M | 2.72M | 3.46M | 2.45M | 3.59M | 3.81M | 3.76M | 3.55M | 3.22M | 2.69M | 2.24M | 282K | 7.42M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47.59M | n/a | n/a | n/a |
Cost & Expenses | 65.66M | 57.17M | 52.22M | 42.75M | 47.69M | 44.52M | 38.14M | 34.35M | 36.52M | 39.24M | 38.37M | 34.18M | 35.32M | 35.52M | 36.09M | 34.79M | 35.85M | 33.6M |
Income Tax Expense | 1.01M | -392K | 2.65M | 91K | 38K | 54K | 3.85M | -9K | 54K | 21K | 69K | 709K | 32K | 325K | 1.14M | n/a | 312K | n/a |
Shares Outstanding (Basic) | 47.74M | 47.42M | 47.03M | 43.1M | 36.82M | 33.38M | 36.15M | 32.3M | 23.46M | 23.28M | 23.09M | 22.8M | 22.7M | 22.63M | 22.43M | 22.38M | 22.33M | 22.24M |
Shares Outstanding (Diluted) | 47.74M | 47.42M | 47.03M | 43.1M | 36.82M | 33.38M | 36.15M | 32.3M | 23.46M | 23.28M | 23.09M | 22.8M | 22.7M | 22.63M | 22.43M | 22.38M | 22.33M | 22.24M |
EPS (Basic) | -1.05 | -0.92 | -0.8 | -0.55 | -0.91 | -0.97 | -0.72 | -0.68 | -1.03 | -1.3 | -1.22 | -1.13 | -1.18 | -1.25 | -1.27 | -1.35 | -1.17 | -1.17 |
EPS (Diluted) | -1.05 | -0.92 | -0.8 | -0.55 | -0.91 | -0.97 | -0.72 | -0.68 | -1.03 | -1.3 | -1.22 | -1.13 | -1.18 | -1.25 | -1.27 | -1.35 | -1.17 | -1.17 |
EBITDA | -41.45M | -36.91M | -24.6M | -14.68M | -25.58M | -23.77M | -7.42M | -12.18M | -14.55M | -26.2M | -19.43M | -17.17M | -18.11M | -21.5M | -19.46M | -22.93M | -22.28M | -25.69M |
EBIT | -40.15M | -34.8M | -24.91M | -14.95M | -25.84M | -24.13M | -7.85M | -12.59M | -14.98M | -26.64M | -24.96M | -17.61M | -18.59M | -21.95M | -19.91M | -23.38M | -22.72M | -26.11M |
Depreciation & Amortization | n/a | 497K | 306K | 266K | 263K | 351K | 424K | 415K | 431K | 435K | 450K | 435K | 476K | 456K | 451K | 452K | 442K | 428K |